All In Biotech

Drug Trial Radar · NCT07324616

A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment

A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics of a Single Oral Dose of EDG-7500 in Participants With Impaired and Normal Hepatic Function

Last checked: Nov 19, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

25

Actual

Start

Jan 26, 2026

Primary completion

Apr 7, 2026

Study completion Apr 7, 2026

Sponsor

Lead sponsor
Edgewise Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jan 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this Phase 1 study is to understand and compare the amount of EDG-7500 in the blood after a single dose in participants with different levels of liver function impairment versus participants with normal liver function. The safety of EDG-7500 in adult participants with different levels of liver function impairment will also be evaluated in this study.

Conditions

  • Hepatic Impairment (HI)

Interventions

  • EDG-7500Drug

    Single dose of EDG-7500

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the plasma concentration time-curve from time zero to the last measured concentration (AUC0-last)Time frame: Pre-dose to day 10
  2. Area under the plasma concentration time-curve from time zero extrapolated to infinity (AUC0-inf)Time frame: Pre-dose to day 10
  3. Maximum observed plasma concentration (Cmax)Time frame: Pre-dose to day 10

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • The University of Miami Division of Clinical Pharmacology

    Miami, Florida

  • Orlando Clinical Research Center

    Orlando, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.